GT
Glenmede Trust Portfolio holdings
AUM
$18.6B
1-Year Return
8.78%
This Quarter Return
-2.31%
1 Year Return
+8.78%
3 Year Return
+33.81%
5 Year Return
+160.7%
10 Year Return
+249.02%
AUM
$18.6B
AUM Growth
-$964M
(-4.9%)
Cap. Flow
-$258M
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
23.99%
Holding
1,457
New
73
Increased
510
Reduced
666
Closed
86
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$40.2M |
| 2 |
iShares Russell 2500 ETF
SMMD
|
+$32.1M |
| 3 |
Putnam Focused Large Cap Value ETF
PVAL
|
+$27M |
| 4 |
Merck
MRK
|
+$19.8M |
| 5 |
America Movil
AMX
|
+$18.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$44.9M |
| 2 |
Dick's Sporting Goods
DKS
|
+$26.9M |
| 3 |
IQVIA
IQV
|
+$26.6M |
| 4 |
ServiceNow
NOW
|
+$24.7M |
| 5 |
Kontoor Brands
KTB
|
+$21.2M |
Sector Composition
| 1 | Technology | 21.74% |
| 2 | Financials | 11.1% |
| 3 | Healthcare | 10.57% |
| 4 | Consumer Discretionary | 8.46% |
| 5 | Industrials | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Crane NXT
CXT
$3.5B
| $269K | ﹤0.01% |
+5,228
| New | +$269K |
|
1127
NVR
NVR
$22.9B
| $268K | ﹤0.01% |
37
+3
| +9% | +$21.7K |
|
1128
Corcept Therapeutics
CORT
$7.62B
| $267K | ﹤0.01% |
+2,337
| New | +$267K |
|
1129
Soleno Therapeutics
SLNO
$3.66B
| $265K | ﹤0.01% |
+3,711
| New | +$265K |
|
1130
SPDR MSCI EAFE StrategicFactors ETF
QEFA
$934M
| $265K | ﹤0.01% |
3,350
-1,446
| -30% | -$114K |
|
1131
MoonLake Immunotherapeutics
MLTX
$3.59B
| $261K | ﹤0.01% |
+6,690
| New | +$261K |
|
1132
HUB Group
HUBG
$2.22B
| $260K | ﹤0.01% |
+6,988
| New | +$260K |
|
1133
Bunge Global
BG
$16.6B
| $259K | ﹤0.01% |
3,395
-1,436
| -30% | -$110K |
|
1134
iShares MSCI Canada ETF
EWC
$3.25B
| $259K | ﹤0.01% |
6,360
| – | – |
|
1135
Genmab
GMAB
$17.1B
| $258K | ﹤0.01% |
13,193
+2,183
| +20% | +$42.7K |
|
1136
FormFactor
FORM
$2.25B
| $258K | ﹤0.01% |
9,130
-407
| -4% | -$11.5K |
|
1137
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
| $257K | ﹤0.01% |
2,513
+485
| +24% | +$49.6K |
|
1138
iShares US Home Construction ETF
ITB
$3.25B
| $256K | ﹤0.01% |
2,685
+10
| +0.4% | +$952 |
|
1139
Ingevity
NGVT
$2.14B
| $255K | ﹤0.01% |
6,453
+1,085
| +20% | +$43K |
|
1140
Provident Financial Services
PFS
$2.59B
| $253K | ﹤0.01% |
14,729
-1,577
| -10% | -$27.1K |
|
1141
Replimune Group
REPL
$450M
| $253K | ﹤0.01% |
+25,917
| New | +$253K |
|
1142
Vaxcyte
PCVX
$4.24B
| $252K | ﹤0.01% |
6,664
+19
| +0.3% | +$717 |
|
1143
Global X Internet of Things ETF
SNSR
$226M
| $251K | ﹤0.01% |
7,607
-583
| -7% | -$19.2K |
|
1144
iShares Global Tech ETF
IXN
$5.9B
| $250K | ﹤0.01% |
3,300
| – | – |
|
1145
Vanguard S&P 500 Growth ETF
VOOG
$19.8B
| $249K | ﹤0.01% |
745
| – | – |
|
1146
Nutrien
NTR
$27.6B
| $249K | ﹤0.01% |
+5,009
| New | +$249K |
|
1147
Royal Bank of Canada
RY
$204B
| $248K | ﹤0.01% |
2,202
+9
| +0.4% | +$1.01K |
|
1148
CGI
GIB
$21.3B
| $244K | ﹤0.01% |
2,447
+29
| +1% | +$2.9K |
|
1149
Distillate US Fundamental Stability & Value ETF
DSTL
$1.81B
| $244K | ﹤0.01% |
4,500
| – | – |
|
1150
Dolby
DLB
$6.9B
| $243K | ﹤0.01% |
3,024
-17
| -0.6% | -$1.37K |
|